Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Latrunculin A Accelerates Actin Filament Depolymerization in Addition to Sequestering Actin Monomers.

Fujiwara I, Zweifel ME, Courtemanche N, Pollard TD.

Curr Biol. 2018 Oct 8;28(19):3183-3192.e2. doi: 10.1016/j.cub.2018.07.082. Epub 2018 Sep 27.

2.

Dissection of two parallel pathways for formin-mediated actin filament elongation.

Sherer LA, Zweifel ME, Courtemanche N.

J Biol Chem. 2018 Nov 16;293(46):17917-17928. doi: 10.1074/jbc.RA118.004845. Epub 2018 Sep 28.

3.

Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients.

Zweifel M, Thürlimann B, Riniker S, Weder P, von Moos R, Pagani O, Bigler M, Rothgiesser KM, Pilop C, Hawle H, Brauchli P, Tapia C, Schoenfeld W, Sessa C; Swiss Group for Clinical Cancer Research (SAKK).

Endocr Connect. 2017 Oct;6(7):549-556. doi: 10.1530/EC-17-0174. Epub 2017 Aug 16.

4.

Successful Treatment of Pituitary Germinoma with Etoposide, Cisplatin, Vincristine, Methotrexate and Bleomycin Chemotherapy Without Radiotherapy.

Scherz A, Feller K, Berezowska S, Genitsch V, Zweifel M.

Anticancer Res. 2017 Jun;37(6):3111-3115.

PMID:
28551652
5.

Granulocyte Colony-stimulating Factor Producing Anaplastic Carcinoma of the Pancreas: Case Report and Review of the Literature.

Vinzens S, Zindel J, Zweifel M, Rau T, Gloor B, Wochner A.

Anticancer Res. 2017 Jan;37(1):223-228.

PMID:
28011495
6.

Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse.

Gössi F, Spahn M, Zweifel M, Panagiotis S, Mischo A, Stenner F, Hess U, Berthold D, Bargetzi M, Schardt J, Pabst T.

Bone Marrow Transplant. 2017 Feb;52(2):334-336. doi: 10.1038/bmt.2016.285. Epub 2016 Nov 28. No abstract available.

PMID:
27892951
7.

Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm.

Richani M, Kolly P, Knoepfli M, Herrmann E, Zweifel M, von Tengg-Kobligk H, Candinas D, Dufour JF.

Ann Hepatol. 2016 Jan-Feb;15(1):82-90.

8.

Do Not Give Up.

Roux RL, Hall MR, Rustin GJS, Zweifel M.

Int J Gynecol Cancer. 2017 Jul;27(6):1060-1062. doi: 10.1097/IGC.0000000000000584. No abstract available.

9.

Androgen receptor status is highly conserved during tumor progression of breast cancer.

Grogg A, Trippel M, Pfaltz K, Lädrach C, Droeser RA, Cihoric N, Salhia B, Zweifel M, Tapia C.

BMC Cancer. 2015 Nov 9;15:872. doi: 10.1186/s12885-015-1897-2.

10.

Neutrophil expression of ICAM1, CXCR1, and VEGFR1 in patients with breast cancer before and after adjuvant chemotherapy.

Lohri C, Schaltegger CS, VAN DEN Broek M, Wenger RH, Ruegg C, Fink D, Fehr MK, Knuth A, Zweifel M.

Anticancer Res. 2014 Sep;34(9):4693-9.

11.

Detection of pulmonary amylase activity in exhaled breath condensate.

Zweifel M, Rechsteiner T, Hofer M, Boehler A.

J Breath Res. 2013 Dec;7(4):046007. doi: 10.1088/1752-7155/7/4/046007. Epub 2013 Nov 28.

PMID:
24287549
12.

RP1 is a phosphorylation target of CK2 and is involved in cell adhesion.

Stenner F, Liewen H, Göttig S, Henschler R, Markuly N, Kleber S, Faust M, Mischo A, Bauer S, Zweifel M, Knuth A, Renner C, Wadle A.

PLoS One. 2013 Jul 3;8(7):e67595. doi: 10.1371/journal.pone.0067595. Print 2013.

13.

Therapy response with diffusion MRI: an update.

Bains LJ, Zweifel M, Thoeny HC.

Cancer Imaging. 2012 Sep 28;12:395-402. Review.

14.

Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer.

Nathan P, Zweifel M, Padhani AR, Koh DM, Ng M, Collins DJ, Harris A, Carden C, Smythe J, Fisher N, Taylor NJ, Stirling JJ, Lu SP, Leach MO, Rustin GJ, Judson I.

Clin Cancer Res. 2012 Jun 15;18(12):3428-39. doi: 10.1158/1078-0432.CCR-11-3376. Epub 2012 May 29.

15.

Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial.

Cummings J, Zweifel M, Smith N, Ross P, Peters J, Rustin G, Price P, Middleton MR, Ward T, Dive C.

Br J Cancer. 2012 May 22;106(11):1766-71. doi: 10.1038/bjc.2012.165. Epub 2012 Apr 26.

16.

Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors.

Patterson DM, Zweifel M, Middleton MR, Price PM, Folkes LK, Stratford MR, Ross P, Halford S, Peters J, Balkissoon J, Chaplin DJ, Padhani AR, Rustin GJ.

Clin Cancer Res. 2012 Mar 1;18(5):1415-25. doi: 10.1158/1078-0432.CCR-11-2414. Epub 2012 Jan 10.

17.

Biologicals in the upfront treatment of ovarian cancer: focus on bevacizumab and poly (adp-ribose) polymerase inhibitors.

Roux R, Zweifel M, Rustin GJ.

Am Soc Clin Oncol Educ Book. 2012:340-4. doi: 10.14694/EdBook_AM.2012.32.340.

PMID:
24451760
18.

Autologous stem cell transplantation: leukapheresis product has anti-angiogenic effects in vivo correlating with neutrophil-derived VEGFR1.

Luethy A, Stenner F, Lohri C, Muller C, Samaras P, Steiner R, Van Den Broek M, Mischo A, Renner C, Knuth A, Ruegg C, Wenger RH, Zweifel M.

Anticancer Res. 2011 Oct;31(10):3115-24.

PMID:
21965716
19.

Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience.

Samaras P, Blickenstorfer M, Haile SR, Siciliano RD, Petrausch U, Mischo A, Zweifel M, Honegger H, Schanz U, Stussi G, Taverna C, Bauer S, Knuth A, Stenner-Liewen F, Renner C.

Swiss Med Wkly. 2011 May 31;141:w13203. doi: 10.4414/smw.2011.13203. eCollection 2011.

20.

Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer.

Zweifel M, Jayson GC, Reed NS, Osborne R, Hassan B, Ledermann J, Shreeves G, Poupard L, Lu SP, Balkissoon J, Chaplin DJ, Rustin GJ.

Ann Oncol. 2011 Sep;22(9):2036-41. doi: 10.1093/annonc/mdq708. Epub 2011 Jan 27.

PMID:
21273348
21.

Eotaxin/CCL11 levels correlate with myocardial fibrosis and mast cell density in native and transplanted rat hearts.

Zweifel M, Matozan K, Dahinden C, Schaffner T, Mohacsi P.

Transplant Proc. 2010 Sep;42(7):2763-6. doi: 10.1016/j.transproceed.2010.05.152.

PMID:
20832583
22.

Immediate microvascular breast reconstruction after neoadjuvant chemotherapy: complication rates and effect on start of adjuvant treatment.

Zweifel-Schlatter M, Darhouse N, Roblin P, Ross D, Zweifel M, Farhadi J.

Ann Surg Oncol. 2010 Nov;17(11):2945-50. doi: 10.1245/s10434-010-1195-9. Epub 2010 Jun 29.

PMID:
20585868
23.

Perfusion MRI in the early clinical development of antivascular drugs: decorations or decision making tools?

Zweifel M, Padhani AR.

Eur J Nucl Med Mol Imaging. 2010 Aug;37 Suppl 1:S164-82. doi: 10.1007/s00259-010-1451-z. Review.

PMID:
20461374
24.

A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer.

Rustin GJ, Shreeves G, Nathan PD, Gaya A, Ganesan TS, Wang D, Boxall J, Poupard L, Chaplin DJ, Stratford MR, Balkissoon J, Zweifel M.

Br J Cancer. 2010 Apr 27;102(9):1355-60. doi: 10.1038/sj.bjc.6605650. Epub 2010 Apr 13.

25.

Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP.

Samaras P, Heider H, Haile SR, Petrausch U, Schaefer NG, Siciliano RD, Meisel A, Mischo A, Zweifel M, Knuth A, Stenner-Liewen F, Renner C.

Ann Hematol. 2010 Aug;89(8):783-7. doi: 10.1007/s00277-010-0926-0. Epub 2010 Mar 5.

PMID:
20204361
26.

Increased bone marrow activity on F-18-FDG PET/CT in granulocyte colony stimulating factor producing anaplastic thyroid carcinoma.

Zweifel M, Stenner-Liewen F, Weber A, Samaras P, Zaugg K, Knuth A, Soyka JD.

Clin Nucl Med. 2010 Feb;35(2):103-4. doi: 10.1097/RLU.0b013e3181c7be63. No abstract available.

PMID:
20090458
27.

Eotaxin/CCL11 expression by infiltrating macrophages in rat heart transplants during ongoing acute rejection.

Zweifel M, Mueller C, Schaffner T, Dahinden C, Matozan K, Driscoll R, Mohacsi P.

Exp Mol Pathol. 2009 Oct;87(2):127-32. doi: 10.1016/j.yexmp.2009.07.006. Epub 2009 Jul 23.

PMID:
19631640
28.

Connexin 43 expression in human hypertrophied heart due to pressure and volume overload.

Vetter C, Zweifel M, Zuppinger C, Carrel T, Martin D, Haefliger JA, Delacrétaz E.

Physiol Res. 2010;59(1):35-42. Epub 2009 Feb 27.

29.

Targeted therapeutic approach for an anaplastic thyroid cancer in vitro and in vivo.

Stenner F, Liewen H, Zweifel M, Weber A, Tchinda J, Bode B, Samaras P, Bauer S, Knuth A, Renner C.

Cancer Sci. 2008 Sep;99(9):1847-52. doi: 10.1111/j.1349-7006.2008.00882.x. Epub 2008 Jul 4.

30.

Treatment of POEMS syndrome with bevacizumab.

Samaras P, Bauer S, Stenner-Liewen F, Steiner R, Zweifel M, Renner C, Knuth A.

Haematologica. 2007 Oct;92(10):1438-9.

31.

Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas.

Leyvraz S, Zweifel M, Jundt G, Lissoni A, Cerny T, Sessa C, Fey M, Dietrich D, Honegger HP; Swiss Group for Clinical Cancer Research.

Ann Oncol. 2006 Apr;17(4):646-51. Epub 2006 Feb 24.

32.

Structure and Notch receptor binding of the tandem WWE domain of Deltex.

Zweifel ME, Leahy DJ, Barrick D.

Structure. 2005 Nov;13(11):1599-611.

33.

Restoration of hepatic mast cells and expression of a different mast cell protease phenotype in regenerating rat liver after 70%-hepatectomy.

Zweifel M, Breu K, Matozan K, Renner E, Welle M, Schaffner T, Clavien PA.

Immunol Cell Biol. 2005 Dec;83(6):587-95.

PMID:
16266310
34.

Effects of stress on alcohol consumption in rats selectively bred for high or low alcohol drinking.

Chester JA, Blose AM, Zweifel M, Froehlich JC.

Alcohol Clin Exp Res. 2004 Mar;28(3):385-93.

PMID:
15084895
35.

Structure and stability of the ankyrin domain of the Drosophila Notch receptor.

Zweifel ME, Leahy DJ, Hughson FM, Barrick D.

Protein Sci. 2003 Nov;12(11):2622-32.

36.

Glycopeptide carboxamides active against vancomycin-resistant enterococci.

Zweifel MJ, Snyder NJ, Cooper RD, Nicas TI, Mullen DL, Butler TF, Rodriguez MJ.

J Antibiot (Tokyo). 2003 Mar;56(3):289-95.

37.
38.

Mast cells in ongoing acute rejection: increase in number and expression of a different phenotype in rat heart transplants.

Zweifel M, Hirsiger H, Matozan K, Welle M, Schaffner T, Mohacsi P.

Transplantation. 2002 Jun 15;73(11):1707-16.

PMID:
12084991
39.
40.
41.

The synthesis of pseudomycin C' via a novel acid promoted side-chain deacylation of pseudomycin A.

Rodriguez MJ, Belvo M, Morris R, Zeckner DJ, Current WL, Sachs RK, Zweifel MJ.

Bioorg Med Chem Lett. 2001 Jan 22;11(2):161-4.

PMID:
11206449
42.

Syntheses and biological evaluation of novel pseudomycin side-chain analogues. Part 2.

Chen SH, Sun X, Boyer R, Paschal J, Zeckner D, Current W, Zweifel M, Rodriguez M.

Bioorg Med Chem Lett. 2000 Sep 18;10(18):2107-10.

PMID:
10999481
43.

Syntheses and antifungal activity of pseudomycin side-chain analogues. Part 1.

Jamison J, Levy S, Sun X, Zeckner D, Current W, Zweifel M, Rodriguez M, Turner W, Chen SH.

Bioorg Med Chem Lett. 2000 Sep 18;10(18):2101-5.

PMID:
10999480
44.
45.

Novel glycopeptide antibiotics: N-alkylated derivatives active against vancomycin-resistant enterococci.

Rodriguez MJ, Snyder NJ, Zweifel MJ, Wilkie SC, Stack DR, Cooper RD, Nicas TI, Mullen DL, Butler TF, Thompson RC.

J Antibiot (Tokyo). 1998 Jun;51(6):560-9.

46.

Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci.

Nicas TI, Mullen DL, Flokowitsch JE, Preston DA, Snyder NJ, Zweifel MJ, Wilkie SC, Rodriguez MJ, Thompson RC, Cooper RD.

Antimicrob Agents Chemother. 1996 Sep;40(9):2194-9.

47.

Reductive alkylation of glycopeptide antibiotics: synthesis and antibacterial activity.

Cooper RD, Snyder NJ, Zweifel MJ, Staszak MA, Wilkie SC, Nicas TI, Mullen DL, Butler TF, Rodriguez MJ, Huff BE, Thompson RC.

J Antibiot (Tokyo). 1996 Jun;49(6):575-81.

48.

Relationship between structure and biological activity of novel R106 analogs.

Rodriguez MJ, Zweifel MJ, Farmer JD, Gordee RS, Loncharich RJ.

J Antibiot (Tokyo). 1996 Apr;49(4):386-9.

49.

Aldol-Promoted Reaction of R106-Sarcosine: Synthesis and Conformational Analysis of Novel R106 Analogs.

Rodriguez MJ, Zweifel MJ, Loncharich RJ.

J Org Chem. 1996 Mar 8;61(5):1564-1572.

PMID:
11667021
50.

Genetic differences in tolerance and sensitization to the sedative/hypnotic effects of alcohol.

Kurtz DL, Stewart RB, Zweifel M, Li TK, Froehlich JC.

Pharmacol Biochem Behav. 1996 Mar;53(3):585-91.

PMID:
8866959

Supplemental Content

Loading ...
Support Center